Mylan Faces Patent Suits Over Generic Estradiol
Units of Novartis AG and Hisamitsu Pharmaceutical Co. Inc. accused Mylan Inc. of infringing two of their patents by seeking to market a generic estradiol transdermal system in a pair of...To view the full article, register now.
Already a subscriber? Click here to view full article